Titre : Triacylglycerol lipase

Triacylglycerol lipase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Hyperplasia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Triacylglycerol lipase : Questions médicales les plus fréquentes", "headline": "Triacylglycerol lipase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Triacylglycerol lipase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Triacylglycerol lipase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carboxylic ester hydrolases", "url": "https://questionsmedicales.fr/mesh/D002265", "about": { "@type": "MedicalCondition", "name": "Carboxylic ester hydrolases", "code": { "@type": "MedicalCode", "code": "D002265", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.352.100" } } }, "about": { "@type": "MedicalCondition", "name": "Triacylglycerol lipase", "alternateName": "Lipase", "code": { "@type": "MedicalCode", "code": "D008049", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Luciana R B Gonçalves", "url": "https://questionsmedicales.fr/author/Luciana%20R%20B%20Gon%C3%A7alves", "affiliation": { "@type": "Organization", "name": "Departamento de Engenharia Química, Universidade Federal do Ceará, Campus do Pici, Bloco 709, Fortaleza 60455760, CE, Brazil." } }, { "@type": "Person", "name": "Roberto Fernandez-Lafuente", "url": "https://questionsmedicales.fr/author/Roberto%20Fernandez-Lafuente", "affiliation": { "@type": "Organization", "name": "Departamento de Biocatálisis, ICP-CSIC, Campus UAM-CSIC, 28049 Madrid, Spain. rfl@icp.csic.es." } }, { "@type": "Person", "name": "Yonghua Wang", "url": "https://questionsmedicales.fr/author/Yonghua%20Wang", "affiliation": { "@type": "Organization", "name": "School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China. yonghw@scut.edu.cn." } }, { "@type": "Person", "name": "Rodolpho R C Monteiro", "url": "https://questionsmedicales.fr/author/Rodolpho%20R%20C%20Monteiro", "affiliation": { "@type": "Organization", "name": "Departamento de Engenharia Química, Universidade Federal do Ceará, Campus do Pici, Fortaleza, Brazil." } }, { "@type": "Person", "name": "Pierre B A Fechine", "url": "https://questionsmedicales.fr/author/Pierre%20B%20A%20Fechine", "affiliation": { "@type": "Organization", "name": "Group of Chemistry of Advanced Materials (GQMat) - Department of Analytical Chemistry and Physic-chemistry, Federal University of Ceará - UFC, Fortaleza, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Benign prostatic hyperplasia associated with white matter hyperintensities in men.", "datePublished": "2023-04-22", "url": "https://questionsmedicales.fr/article/37116223", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clineuro.2023.107738" } }, { "@type": "ScholarlyArticle", "name": "The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia.", "datePublished": "2023-02-02", "url": "https://questionsmedicales.fr/article/36769190", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24032870" } }, { "@type": "ScholarlyArticle", "name": "Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.", "datePublished": "2023-01-04", "url": "https://questionsmedicales.fr/article/36685547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.998447" } }, { "@type": "ScholarlyArticle", "name": "The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35634569", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/CIA.S365282" } }, { "@type": "ScholarlyArticle", "name": "Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37642075", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31557/APJCP.2023.24.8.2861" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Esterases", "item": "https://questionsmedicales.fr/mesh/D004950" }, { "@type": "ListItem", "position": 6, "name": "Carboxylic ester hydrolases", "item": "https://questionsmedicales.fr/mesh/D002265" }, { "@type": "ListItem", "position": 7, "name": "Triacylglycerol lipase", "item": "https://questionsmedicales.fr/mesh/D008049" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Triacylglycerol lipase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Triacylglycerol lipase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Triacylglycerol lipase", "description": "Comment diagnostiquer une déficience en lipase ?\nQuels tests sont utilisés pour évaluer la lipase ?\nQuels symptômes indiquent un problème de lipase ?\nLa lipase est-elle mesurée lors d'une pancréatite ?\nQuels autres marqueurs sont associés à la lipase ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Prostatic+Hyperplasia&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Triacylglycerol lipase", "description": "Quels sont les symptômes d'une hyperlipidémie ?\nComment la déficience en lipase se manifeste-t-elle ?\nLa lipase affecte-t-elle le poids corporel ?\nQuels signes indiquent une inflammation pancréatique ?\nLes douleurs abdominales sont-elles liées à la lipase ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Prostatic+Hyperplasia&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Triacylglycerol lipase", "description": "Comment prévenir les troubles liés à la lipase ?\nLes examens réguliers sont-ils nécessaires ?\nLe contrôle du poids aide-t-il la lipase ?\nLes habitudes alimentaires influencent-elles la lipase ?\nL'exercice régulier est-il bénéfique ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Prostatic+Hyperplasia&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Triacylglycerol lipase", "description": "Comment traiter une déficience en lipase ?\nQuels médicaments peuvent affecter la lipase ?\nLa lipase peut-elle être ciblée par des thérapies ?\nQuels changements alimentaires aident la lipase ?\nLes enzymes pancréatiques sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Prostatic+Hyperplasia&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Triacylglycerol lipase", "description": "Quelles complications peuvent survenir avec une lipase élevée ?\nLa lipase affecte-t-elle la santé cardiovasculaire ?\nQuels risques sont associés à une déficience en lipase ?\nLes troubles lipidiques peuvent-ils causer des AVC ?\nUne lipase anormale peut-elle affecter le foie ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Prostatic+Hyperplasia&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Triacylglycerol lipase", "description": "Quels facteurs augmentent le risque de troubles lipidiques ?\nL'hérédité joue-t-elle un rôle dans les troubles lipidiques ?\nLe tabagisme influence-t-il la lipase ?\nLe stress a-t-il un impact sur la lipase ?\nL'âge est-il un facteur de risque pour la lipase ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Prostatic+Hyperplasia&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en lipase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins mesurant les niveaux de lipase peuvent indiquer une déficience." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la lipase ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de lipase sérique sont couramment utilisés pour évaluer la fonction pancréatique." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de lipase ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des nausées et des vomissements peuvent signaler un problème." } }, { "@type": "Question", "name": "La lipase est-elle mesurée lors d'une pancréatite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de lipase sont souvent élevés en cas de pancréatite aiguë." } }, { "@type": "Question", "name": "Quels autres marqueurs sont associés à la lipase ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'amylase est souvent mesurée en parallèle pour évaluer les troubles pancréatiques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hyperlipidémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des éruptions cutanées et une fatigue." } }, { "@type": "Question", "name": "Comment la déficience en lipase se manifeste-t-elle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des malabsorption des graisses, des diarrhées grasses et des carences nutritionnelles." } }, { "@type": "Question", "name": "La lipase affecte-t-elle le poids corporel ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une déficience peut entraîner une perte de poids due à une mauvaise absorption des graisses." } }, { "@type": "Question", "name": "Quels signes indiquent une inflammation pancréatique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales sévères, des nausées et des vomissements sont des signes d'inflammation." } }, { "@type": "Question", "name": "Les douleurs abdominales sont-elles liées à la lipase ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de lipase peuvent être associés à des douleurs abdominales." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés à la lipase ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une alimentation équilibrée et un mode de vie actif peut aider à prévenir les troubles." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies lipidiques." } }, { "@type": "Question", "name": "Le contrôle du poids aide-t-il la lipase ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un poids santé peut réduire le risque de troubles lipidiques." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la lipase ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut affecter les niveaux de lipase." } }, { "@type": "Question", "name": "L'exercice régulier est-il bénéfique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier aide à réguler le métabolisme lipidique et la lipase." } }, { "@type": "Question", "name": "Comment traiter une déficience en lipase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments enzymatiques pour améliorer la digestion." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter la lipase ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments comme les diurétiques peuvent influencer les niveaux de lipase." } }, { "@type": "Question", "name": "La lipase peut-elle être ciblée par des thérapies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies ciblées peuvent être développées pour traiter des troubles lipidiques spécifiques." } }, { "@type": "Question", "name": "Quels changements alimentaires aident la lipase ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fibres et faible en graisses saturées peut améliorer la santé lipidique." } }, { "@type": "Question", "name": "Les enzymes pancréatiques sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles aident à la digestion des graisses en cas de déficience en lipase." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une lipase élevée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une lipase élevée peut indiquer une pancréatite, entraînant des complications graves." } }, { "@type": "Question", "name": "La lipase affecte-t-elle la santé cardiovasculaire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés de lipides peuvent augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels risques sont associés à une déficience en lipase ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une déficience peut entraîner des malnutritions et des carences en vitamines liposolubles." } }, { "@type": "Question", "name": "Les troubles lipidiques peuvent-ils causer des AVC ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles lipidiques non traités peuvent augmenter le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Une lipase anormale peut-elle affecter le foie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux peuvent être liés à des maladies hépatiques comme la stéatose." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles lipidiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le diabète et une alimentation riche en graisses saturées augmentent le risque." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les troubles lipidiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles lipidiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la lipase ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affecter le métabolisme lipidique et les niveaux de lipase." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la lipase ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut influencer le métabolisme et les niveaux de lipase." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour la lipase ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de troubles lipidiques augmente avec l'âge en raison de changements métaboliques." } } ] } ] }

Sources (10000 au total)

Benign prostatic hyperplasia associated with white matter hyperintensities in men.

Benign prostatic hyperplasia (BPH) describes common noncancerous prostate enlargement. BPH is usually associated with lower urinary tract symptoms and an increased risk of cerebrovascular diseases, su... A total of 788 male patients from the First Affiliated Hospital of Kunming Medical University from July 2019 to September 2021 were enrolled in this cross-sectional study. BPH was assessed by abdomina... Patients with BPH presented an increased risk of WMHs with a crude odds ratio (OR) of 2.76 (95% CI, 2.02-3.79) and an adjusted OR of 1.75 (95% CI, 1.24-2.48) after controlling for potential confoundin... We found that BPH was closely associated with WMHs in male Chinese individuals....

Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.

Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges.... The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS... Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...

The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.

Transurethral resection of the prostate (TURP) is often indicated for benign prostatic hyperplasia (BPH). Some patients, however, fail to adequately respond to these interventions. Accordingly, a powe... Clinical data from 356 BPH subjects who underwent TURP were retrospectively collected between November 2015 and June 2021 for nomogram development. The prediction model was developed using multivariab... In multivariate analysis of the primary cohort, the independent factors for TURP efficacy were age, International Prostate Symptom Score (IPSS), intravesical prostatic protrusion (IPP), bladder wall t... The P.R.OS.T.A.T.E nomogram objectively and accurately predicted TURP efficacy, thereby facilitating the clinical decision-making process....

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study.

This observational comparative study aimed at investigating the diagnostic accuracy of ERG in differentiating benign and malignant prostatic lesions and comparing it to the diagnostic accuracy of AMAC... Seventy- two cases (22 prostatic hyperplasia and 50 prostatic carcinoma) were collected from the pathology department at Cairo university. The cases were immunostained by antibodies against AMACR and ... AMACR showed 62% sensitivity and 86.4% specificity for the diagnosis of PC, with a statistically significant differential expression in benign and malignant lesions (P=0.001). Its expression also corr... Although ERG proved no superior value than AMACR in diagnosing prostatic lesions, combining both markers may lead to higher diagnostic accuracy owing to higher ERG specificity for PC....

The role of FASL, BCL-2 and BAX polymorphisms in brazilian patients with prostate cancer and benign prostatic hyperplasia.

Prostate cancer (PCA) is one of the leading causes of death among men, being related to several factors, including the aging male population, like benign prostatic hyperplasia (BPH), a histopathologic... 348 samples were analyzed, being 123 from PCA patients, 143 BPH patients and 82 healthy controls, using PCR-RFLP techniques. The results of genotyping analysis were adjusted by age, and compared with ... Our data indicate the FASLCC genotype as a risk factor for prostate pathologies, whileBCL-2 CC can act as a protective genotype....

Efficacy and Safety of Transurethral Columnar Balloon Dilation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Multicenter Trial.

To observe the efficacy and safety of transurethral columnar balloon dilation of the prostate (TUCBDP) for benign prostatic hyperplasia (BPH) in a multicenter trial.... This multicenter study included 2050 patients with BPH who underwent TUCBDP from 11 cities of Zhejiang Province, from September 2015 to June 2021. Clinical assessment included recording and measuremen... One month after surgery, the patients' IPSS score, QoL, and PVR were significantly decreased, while the Qmax, IIEF-5, and MSHQ-EjD-SF scores were increased considerably, compared with preoperative dat... Collectively, TUCBDP may effectively improve the urinary and sexual function of BPH patients, with fewer postoperative complications, and its efficacy is not limited by age and prostate volume. It can...

A cross-sectional quality assessment of TikTok content on benign prostatic hyperplasia.

With an increasing reliance on online sources for medical information, we studied the quality and completeness of health literacy videos on TikTok regarding BPH.... A cross-sectional systematic evaluation of TikTok videos using the search term "Benign Prostatic Hyperplasia" was performed on 14th April 2023, and included 49 patient information and educational vide... Of the 49 videos, 38 were created by healthcare professionals (HCPs). The average length of each video was 62.7 ± 59.3 s, with a large average number of total views (24,990.1 ± 109,534.9 views). The D... BPH videos on TikTok have a wide reach, but the videos are mostly of low quality and completeness. Future videos should be made with quality and completeness in mind given the large viewership and mor...

Factors associated with concomitant prostate cancer in benign prostatic hyperplasia patients aged 60 years and above.

Prostate hyperplasia and cancer are more prevalent in middle-aged and elderly men. Previous studies have linked both disorders to androgen receptors. Herein, efforts were made to identify factors asso... An analytical framework was established utilizing the "Prostate Cancer Early Warning Dataset" from the National Clinical Medical Science Data Center. Variables selection was conducted through LASSO re... A total of 1,502 patients with BPH and 294 with combined PCa were hereby included. Multivariate regression delineated several independent predictors of PCa coexistence, including age (OR [95% CI]: 1.0... The analysis revealed connections between PCa occurrence in men aged over 60 and BPH, along with specific serum biomarkers such as inorganic phosphorus, globulin, LDL cholesterol, lower fPSA/tPSA rati...